Structure-Based Screening and Optimization of PafA Inhibitors with Potent Anti-Tuberculosis Activity
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252313189 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hewei Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai 20024…. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, Molecular Docking Simulation. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fourteenth Five-Year National Key Research and Development Program of China, the Natural Science Foundation of China, the R&D Program of Guangzhou National Laboratory.
Abstract (Originalsprache)
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a major global health challenge, primarily due to the increasing prevalence of drug resistance. Consequently, the development of drugs with novel modes of action (MOAs) is urgently required. In this study, we discovered and characterized two potent inhibitors, Pi-1-58 and Pi-2-26, targeting the prokaryotic ubiquitin-like protein (Pup) ligase PafA of Mtb. Pi-1-58 was identified through computer-aided drug screening. The binding mode of Pi-1-58 and PafA was investigated through molecular docking, followed by experimental validations. Based on the core structure of Pi-1-58, we developed a more potent inhibitor, Pi-2-26, through structure-guided drug design. Both Pi-1-58 and Pi-2-26 exhibited selective and specific inhibition of PafA according to biochemical and cell-based assays. Importantly, the inhibitors demonstrated significant inhibition on Mtb survival in the presence of nitric oxide, mimicking the in vivo nitrogen limited environment that Mtb encountered in macrophage. Our findings provide a comprehensive understanding of the structural and functional aspects of these PafA inhibitors and establish a solid foundation for the development of novel therapeutics against tuberculosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.
- Lingang Laboratory, Shanghai 200031, China.
- Center for Quantitative Biology, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
- Institute of Systems Biology, Shenzhen Bay Laboratory, Peking University Shenzhen Graduate School, Shenzhen 518055, China.
- State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.
ORCID-Profile: Xuelian Zhang, Jianfeng Pei, Shengce Tao
Förderung
- Fourteenth Five-Year National Key Research and Development Program of China
- the Natural Science Foundation of China
- the R&D Program of Guangzhou National Laboratory
- Natural Science Foundation of China
- R&D Program of Guangzhou National Laboratory
- National Natural Science Foundation of China
- Anhui’s Plans for Major Provincial Science&Technology Projects
Zitieren
APA
Jiang, H., Xie, J., Wang, L., Chen, H., Zheng, Y., Wang, X., Guo, S., Wang, T., Bi, J., Zhang, X., Pei, J., & Tao, S. (2024). Structure-Based Screening and Optimization of PafA Inhibitors with Potent Anti-Tuberculosis Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313189
Vancouver
Jiang H, Xie J, Wang L, Chen H, Zheng Y, Wang X, et al. Structure-Based Screening and Optimization of PafA Inhibitors with Potent Anti-Tuberculosis Activity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313189
BibTeX
@article{Jiang2024,
author = {Jiang, Hewei and Xie, Jin and Wang, Lei and Chen, Hong and Zheng, Yunxiao and Wang, Xuening and Guo, Shujuan and Wang, Tao and Bi, Jing and Zhang, Xuelian and Pei, Jianfeng and Tao, Shengce},
title = {Structure-Based Screening and Optimization of PafA Inhibitors with Potent Anti-Tuberculosis Activity},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252313189}
}
EUVIMED